Search for
Total Iron Binding Capacity (TIBC)
Anemia
Report in 4Hrs
At Home
No Fasting Required
Details
Total iron binding capacity; helps differentiate between iron deficiency and anemia of chronic disease.
₹129₹440
71% OFF
Total Iron Binding Capacity (TIBC) - Comprehensive Medical Test Guide
- 1. Why is it done?
- Test Measurement: TIBC measures the maximum amount of iron that transferrin (an iron-transport protein) can bind and carry in the blood. It reflects the body's ability to transport iron from the digestive system to tissues.
- Primary Indications: Diagnosis and evaluation of iron metabolism disorders, including iron deficiency anemia, iron overload (hemochromatosis), and chronic liver disease; Assessment of nutritional status and iron homeostasis; Investigation of unexplained anemia or fatigue
- Typical Circumstances: Performed when serum iron levels are abnormal; Part of iron studies panel (includes serum iron, ferritin, and transferrin saturation); Routine screening in patients with symptoms of anemia (weakness, shortness of breath, pallor) or iron overload conditions; Monitoring patients on iron supplementation or those with known iron metabolism disorders
- 2. Normal Range
- Reference Values: Adults: 250-425 µg/dL (44.75-76.06 µmol/L); Ranges may vary slightly between laboratories due to different measurement methods and equipment
- Units of Measurement: Micrograms per deciliter (µg/dL) or micromoles per liter (µmol/L)
- Normal Results Interpretation: Indicates normal iron transport capacity; Body has adequate transferrin available to bind iron; Suggests normal iron metabolism and nutritional status; No evidence of significant iron deficiency or overload
- Abnormal Values: High TIBC (>425 µg/dL): May indicate iron deficiency anemia, pregnancy, or certain liver conditions; Low TIBC (<250 µg/dL): May suggest iron overload, hemochromatosis, liver disease, chronic illness, or malnutrition
- 3. Interpretation
- Elevated TIBC (>425 µg/dL): Indicates reduced serum iron levels and increased transferrin production; Body compensates for low iron by producing more iron-binding protein; Common in iron deficiency anemia, where the body attempts to maximize iron transport despite low availability; Also seen in pregnancy, oral contraceptive use, hepatitis, and acute inflammation
- Decreased TIBC (<250 µg/dL): Suggests reduced transferrin production or function; Associated with iron overload states where the body reduces iron-binding capacity; Seen in hemochromatosis (genetic iron overload), cirrhosis, chronic hepatitis, hemolytic anemia, malnutrition, and protein deficiency; Also occurs in chronic kidney disease and inflammation
- Transferrin Saturation Analysis: Calculate by dividing serum iron by TIBC and multiplying by 100; Normal range: 20-50%; High saturation (>45-50%) with low TIBC suggests iron overload; Low saturation (<20%) with high TIBC suggests iron deficiency
- Factors Affecting Results: Estrogen levels (oral contraceptives increase TIBC); Liver function status; Nutritional status and protein intake; Medications (some antibiotics, anticonvulsants); Recent blood transfusions; Time of day (slight diurnal variation); Stress and inflammation; Kidney disease affecting transferrin synthesis
- Clinical Significance Patterns: TIBC + Low serum iron + High ferritin = Iron deficiency anemia; TIBC + High serum iron + High ferritin = Hemochromatosis or iron overload; Normal TIBC + Normal iron + Normal ferritin = Healthy iron metabolism; Decreased TIBC + Abnormal liver function = Hepatic disease or malnutrition
- 4. Associated Organs
- Primary Organ Systems: Liver (synthesizes transferrin); Bone marrow (produces red blood cells and hematopoietic cells); Gastrointestinal tract (absorbs dietary iron); Kidneys (produce erythropoietin which stimulates iron-dependent RBC production)
- Conditions Associated with Abnormal Results: Iron Deficiency Anemia (elevated TIBC); Hemochromatosis/Iron Overload (decreased TIBC); Liver Cirrhosis and Hepatitis (variable TIBC); Chronic Kidney Disease (decreased TIBC); Hemolytic Anemia (variable); Malabsorption Syndromes (elevated TIBC); Pregnancy and Hormonal Changes (elevated TIBC); Inflammatory Diseases (decreased TIBC); Protein Malnutrition (decreased TIBC); Hypothyroidism (may affect TIBC)
- Diseases Diagnosed or Monitored: Hereditary Hemochromatosis (HFE mutation); Secondary Hemochromatosis (thalassemia, repeated transfusions); Iron Deficiency Anemia from various causes; Sideroblastic Anemia; Autoimmune Hemolytic Anemia; Chronic Liver Disease; Renal Failure; Nutritional Disorders
- Potential Complications of Abnormal Results: Iron deficiency: Severe anemia, heart palpitations, syncope, reduced work capacity, impaired cognitive function; Iron overload: Cardiac arrhythmias, heart failure, hepatic cirrhosis, pancreatic damage (diabetes), endocrine dysfunction, arthropathy; Untreated conditions may lead to organ failure, life-threatening anemia, or irreversible tissue damage
- 5. Follow-up Tests
- Complementary Iron Studies: Serum Iron (measures actual iron in blood); Ferritin (indicates iron storage); Transferrin Saturation (calculated as serum iron/TIBC × 100); Soluble Transferrin Receptor (reflects iron demand); These tests are typically ordered together as an iron panel
- Anemia Workup Tests: Complete Blood Count (CBC) to assess hemoglobin, hematocrit, RBC indices; Peripheral Blood Smear for cell morphology; Reticulocyte Count (indicates bone marrow response); B12 and Folate levels; Blood Glucose and Thyroid Function Tests
- Genetic and Hepatic Assessment: HFE gene mutation testing (if hemochromatosis suspected); Liver Function Tests (ALT, AST, albumin, bilirubin); Liver Imaging (ultrasound, MRI) for fibrosis or cirrhosis; Liver Biopsy (in some hemochromatosis cases)
- Investigations for Iron Deficiency: Gastrointestinal Evaluation (endoscopy, colonoscopy for bleeding); Fecal Occult Blood Test; Stool Studies for malabsorption; Celiac screening (tissue transglutaminase antibodies); Evaluation of menstrual history in women of childbearing age
- Monitoring and Surveillance: Repeat TIBC and iron studies: Every 3-6 months during iron supplementation therapy; Annually in stable iron deficiency or overload patients; More frequently if adjusting treatment; Cardiac monitoring if significant iron overload; Regular liver function tests in hemochromatosis patients
- Related Diagnostic Tests: Serum Albumin (protein synthesis marker); Prothrombin Time (liver synthetic function); Kidney Function Tests (creatinine, BUN); Inflammatory markers (CRP, ESR); Tissue Iron Quantification (MRI T2* imaging for cardiac and hepatic iron); Cardiac Echocardiogram (if cardiomyopathy suspected)
- 6. Fasting Required?
- Fasting Requirement: YES - Fasting is required for TIBC testing
- Fasting Duration: Minimum 12 hours overnight fast is standard; Some labs may require 8-10 hours; Extended fasting periods (24+ hours) are not necessary and may affect other markers
- Fasting Instructions: No food or caloric beverages after midnight (or 12 hours before collection); Water is permitted and encouraged; No juice, coffee, tea, or milk; No chewing gum or tobacco products; Complete fasting improves accuracy of iron and transferrin measurements, as food intake can temporarily affect serum iron levels
- Medications: Take regular medications with small amounts of water as usual unless otherwise instructed; Inform the phlebotomist of all medications, supplements, and iron-containing products; Iron supplements should ideally be discontinued 24 hours before testing (if possible and medically appropriate) to avoid falsely elevated serum iron; Estrogen-containing oral contraceptives, antibiotics, and anticonvulsants should be reported to the lab
- Additional Preparation Requirements: Blood collection should be performed in the morning for standardization (circadian rhythm variation); Avoid strenuous exercise 24 hours before the test; Minimize physical and emotional stress; Avoid prolonged tourniquet application during blood draw; Use of lavender-top EDTA tube or appropriate lab-specified collection tube; Sit for 5 minutes before blood draw to ensure stable measurements; Patient identification and specimen labeling verification; Inform healthcare provider of recent blood transfusions or phlebotomy procedures (within 1-2 days)
How our test process works!
